Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,789 | 1,341 | 88.3% |
| Consulting Fee | $2,375 | 3 | 10.6% |
| Education | $234.67 | 12 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,868 | 132 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $2,511 | 50 | $0 (2023) |
| ABBVIE INC. | $1,829 | 98 | $0 (2024) |
| Novo Nordisk Inc | $1,476 | 142 | $0 (2024) |
| Lilly USA, LLC | $1,271 | 104 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,112 | 70 | $0 (2024) |
| Astellas Pharma US Inc | $1,104 | 58 | $0 (2024) |
| PFIZER INC. | $1,032 | 122 | $0 (2024) |
| Amgen Inc. | $956.13 | 58 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $908.95 | 69 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,335 | 104 | AstraZeneca Pharmaceuticals LP ($662.89) |
| 2023 | $2,096 | 111 | ABBVIE INC. ($478.87) |
| 2022 | $2,822 | 154 | ABBVIE INC. ($658.08) |
| 2021 | $2,262 | 138 | AbbVie Inc. ($404.93) |
| 2020 | $1,895 | 133 | AstraZeneca Pharmaceuticals LP ($387.59) |
| 2019 | $2,754 | 235 | Novo Nordisk Inc ($342.39) |
| 2018 | $3,746 | 257 | Medicure Pharma Inc. ($660.00) |
| 2017 | $4,489 | 224 | SANOFI-AVENTIS U.S. LLC ($1,998) |
All Payment Transactions
1,356 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/10/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Diabetes Care | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Biological | ||||||
| 10/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Inflammation | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Diabetes Care | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.50 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 700 | 1,446 | $158,593 | $85,860 |
| 2022 | 16 | 827 | 1,878 | $193,291 | $102,229 |
| 2021 | 26 | 1,015 | 1,868 | $224,969 | $116,730 |
| 2020 | 22 | 1,010 | 2,012 | $232,838 | $101,305 |
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 110 | 615 | $52,275 | $26,269 | 50.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 233 | $41,940 | $19,994 | 47.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 82 | $20,008 | $9,678 | 48.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 52 | 52 | $6,760 | $6,371 | 94.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 111 | $13,209 | $6,285 | 47.6% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 53 | 75 | $7,500 | $5,290 | 70.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 58 | 58 | $5,220 | $4,291 | 82.2% |
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Office | 2023 | 39 | 39 | $3,900 | $2,490 | 63.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 31 | 31 | $2,480 | $2,345 | 94.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 39 | $1,170 | $1,145 | 97.9% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 12 | 12 | $2,052 | $599.35 | 29.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 37 | 61 | $1,281 | $580.72 | 45.3% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 11 | 11 | $506.00 | $368.39 | 72.8% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 16 | 16 | $160.00 | $97.76 | 61.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 11 | 11 | $132.00 | $55.88 | 42.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 127 | 606 | $51,135 | $28,147 | 55.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 367 | $66,060 | $25,572 | 38.7% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 110 | 172 | $17,200 | $12,847 | 74.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 49 | 64 | $15,616 | $8,470 | 54.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 64 | 64 | $8,320 | $8,080 | 97.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 139 | $16,541 | $7,953 | 48.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 63 | 63 | $5,670 | $4,896 | 86.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 27 | 27 | $2,160 | $1,897 | 87.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 16 | 28 | $3,348 | $1,342 | 40.1% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 23 | 23 | $2,300 | $848.93 | 36.9% |
About Dr. Faozan Narvel, M.D
Dr. Faozan Narvel, M.D is a Family Medicine healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215901020.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Faozan Narvel, M.D has received a total of $22,398 in payments from pharmaceutical and medical device companies, with $2,335 received in 2024. These payments were reported across 1,356 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($19,789).
As a Medicare-enrolled provider, Narvel has provided services to 3,552 Medicare beneficiaries, totaling 7,204 services with total Medicare billing of $406,124. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Columbus, OH
- Active Since 02/16/2006
- Last Updated 11/07/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215901020
Products in Payments
- FARXIGA (Drug) $1,949
- SOLIQUA (Drug) $1,852
- JARDIANCE (Drug) $1,138
- Ozempic (Drug) $683.70
- XARELTO (Drug) $669.42
- ZYPITAMAG (pitavastatin) (Drug) $660.00
- VRAYLAR (Drug) $646.29
- UBRELVY (Drug) $608.94
- Aimovig (Biological) $531.33
- QULIPTA (Drug) $531.07
- CHANTIX (Drug) $476.13
- JANUVIA (Drug) $433.85
- Vascepa (Drug) $431.18
- NURTEC ODT (Drug) $421.16
- Kerendia (Drug) $403.91
- ENTRESTO (Drug) $397.89
- TRADJENTA (Drug) $379.32
- Myrbetriq (Drug) $339.53
- SOLIQUA 100/33 (Biological) $332.37
- ELIQUIS (Drug) $321.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Columbus
Brian Beesley, Do, DO
Family Medicine — Payments: $1.5M
Dr. Jeffrey Kingsley, D.o, D.O
Family Medicine — Payments: $407,144
Dr. Joseph Surber, Do, DO
Family Medicine — Payments: $147,174
Bantwal Baliga, Md,Dgo, MD,DGO
Family Medicine — Payments: $124,562
Bryan Feldman, D.o, D.O
Family Medicine — Payments: $48,287
Elizabeth Martin, M.d, M.D
Family Medicine — Payments: $27,168